yourEra Tirzepatide Review: Cost, Compounded vs Brand & Honest Verdict (2026)

yourEra is a compounded-only telehealth brand that publishes its prices openly — a genuine plus in a category where many competitors hide cost behind a quiz. Its tirzepatide is a weekly injectable at $299/month, with both molecules available and a broad longevity menu, plus an optional coaching/nutritionist/labs membership. This review covers what yourEra is, what it dispenses, the compounded-versus-brand distinction, its real pricing, and the catches. We disclose an affiliate relationship with yourEra; it never changes our scoring, and every fact here comes from yourEra's own program.

What yourEra is

yourEra ("A New Era of Personalized Health") is a compounded-only telehealth brand. A licensed clinician reviews an online intake and, where appropriate, compounded tirzepatide ships as a weekly injectable at $299/month, with compounded semaglutide from $199/month on the same platform. The broader menu adds NAD+ from $249/month and microdosing protocols from $179/month, plus an optional yourEra Optimum membership (+$149/month) that bundles 1:1 coaching, a nutritionist, at-home lab draws, and wearables. yourEra markets a 50-state licensed-clinician network with no insurance required and HSA/FSA accepted; the 50-state reach and efficacy claims are self-reported.

The compounded-vs-brand question

Two very different products share the name tirzepatide:

• •Brand tirzepatide is Eli Lilly's FDA-approved Zepbound (weight management, obstructive sleep apnea) and Mounjaro (type 2 diabetes) — the exact molecule and dose studied in the pivotal trials.
• •Compounded tirzepatide is pharmacy-made, not FDA-approved, and was not the product tested in those trials.

yourEra is compounded only — injectable, with no brand-name or oral pathway. That distinction matters more in 2026: the FDA declared the tirzepatide shortage resolved in October 2024, and the enforcement discretion that permitted routine large-scale compounding ended in early 2025 (around February 18, 2025 for 503A pharmacies, March 19, 2025 for 503B outsourcing facilities), and compounding availability can tighten further as brand shortages resolve — the full timeline is in our guide to whether compounded tirzepatide is still legal in 2026.

What yourEra costs in 2026

yourEra's headline is transparent, publicly listed pricing — many compounded competitors hide the price behind a quiz, so publishing it openly is a real point in yourEra's favor. Compounded tirzepatide is $299/month as a weekly injectable; semaglutide starts at $199/month; microdosing from $179/month; and NAD+ from $249/month. The optional Optimum membership adds $149/month for 1:1 coaching, a nutritionist, at-home labs, and wearables — useful if you want structured support, but a meaningful add-on to the base price. At $299/month, tirzepatide here is mid-market — above the cheapest compounders (roughly $99–$150) but below brand.

For context, LillyDirect sells brand Zepbound self-pay vials at roughly $299–$449/month depending on dose (prices effective February 23, 2026; 28-day supply). For the full cash-price picture, see our Zepbound cost and savings guide.

How the care model holds up

yourEra's strengths are transparent, publicly listed pricing, both molecules plus a broad menu (NAD+, microdosing, and an optional coaching/nutritionist/labs bundle), and a marketed 50-state clinician network with HSA/FSA accepted. The trade-offs: the tirzepatide is compounded and not FDA-approved, and compounding availability can tighten as brand shortages resolve; the $299/month price is mid-market — above the cheapest compounders; there is no brand-name and no oral pathway (injectable only); and yourEra has a thin independent footprint with few third-party reviews, with the 50-state and efficacy claims self-reported. Tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Separate the provider from the medication, and the brand molecule from a compounded copy. Brand tirzepatide's efficacy is trial-grade: in the 72-week SURMOUNT-1 trial, adults without diabetes lost on average roughly 15% to 21% of body weight across the 5–15 mg doses, versus about 3% on placebo¹; against semaglutide in SURMOUNT-5, tirzepatide produced significantly greater weight loss — about 20% versus 14%². Those results were established with the brand molecule; compounded versions were never tested in those trials, so the trial efficacy cannot simply be assumed to transfer, and yourEra's efficacy claims are self-reported. The full picture is in our tirzepatide evidence guide.

The honest verdict

yourEra is a reasonable mid-market pick if you value transparent, published pricing, both molecules, and the option of a coaching/nutritionist/labs bundle — and you are comfortable with a compounded, non-FDA-approved injectable. The reservations are its mid-market $299/month price (above the cheapest compounders), the lack of brand or oral pathways, and a thin independent track record with self-reported claims. If lowest price with included support is your priority, weigh CoreAge Rx's flat $149; if you specifically want brand tirzepatide, price it against LillyDirect. See our best tirzepatide providers ranking and best place to get Zepbound online roundup.